MedDevice formerly MLAB ymb MedDevice formerly MLAB19

New Post Public Reply Private Reply Replies (1) Message Board
crazyjogger925
742

MedDevice formerly MLAB ymb
MedDevice formerly MLAB19 minutes ago
Dear Longs and BOD at CYDY,
I appreciate the chatter about GSK and other Big Pharma interest in Leronlimab. The interest is long over due by Big Pharma, but let us not lose site of Leronlimab's market potential. Any non-revenue company negotiates from a position of potential. We have no revenue track record. We have leverage, if there are more than one interested player. IMHO I believe we have more than one. I have been fortunate to be close enough to these type of negotiations in my past ( I was feeding market information into our negotiation team members). We had no revenue but had developed a novel medical device that had potential to treat different arrhythmias.
In CYDY's case, Leronimab has multiple indications in which we have evidence of strong potential. Market info is from (synthesis 1 2021 Seeking Alpha)
1) HIV monotherapy and combination therapy is $14 billion market size just in the U.S.
2) Conservative estimates on Long Covid are $324 billion. Just 10% of that and it is $32 billion
3) Breast cancer alone in 2019 was $21.58 billion
4) The global solid tumor market in 2018 was $121.3 billion
5) NASH by 2029 is projected to be $84.3 billion
We have so many more indications that Leronlimab has potential to address, but just look at the above indications: HIV, Long Covid, Breast cancer, Solid tumor and NASH total addressable market size and it is = $565.18 billion. Just getting 10% of that is $56 billion. THERE IS NO WAY we should ever accept $10 per share.
Remember that SK stated that Leronlimab could be like Abbvie's HUMIRA and HUMIRA earned approximately $20.7 billion last year.
I believe that Ms. Urbach and Dr. Arman and other CYDY officers on the negotiation team, will not be using historical buyout numbers, because that is extremely limiting. However, I would expect GSK and the other Pharma players to use a historical approach. Thats how these things start out and eventually both sides start to move a lot closer or a little closer. We'll know when things are announced.
I do not know if we will be in a partnership or a buyout. If it is a buyout, it better be significantly more than $10 per share. You know how some posters say "know what you own"; I say know what it's worth and CYDY is worth a ton more than $10 per share.
CYDY management put out the call for 350 million more shares by August 31. IMHO that was a calculated move to set a psuedo-deadline on discussions. If it is a buyout before August 31, the price is X times 1 billion shares or after August 31 it is X times 1.35 billion shares.
"Aim high" my fellow longs!

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fintech Shake-Up: OPay's $4B NYSE IPO Arrival

Updated Category News Views 23

It's a big day on Wall Street as OPay dives into the NYSE with a hefty market cap of over $4 billion, signaling a major moment for the fintech arena. Oh, how times are shifting! Today marks the debut of OPay under the ticker 'OPAY,' and let me tell you, there's a buzz in the air that could quicken any seasoned trader's pulse. OPay's Big Day: A New Era of Fintech Their...

Continue Reading
AI, GLP-1, and the Food Revolution Unveiled

Updated Category News Views 147

How the Food Industry Faces a Formulation Shake-Up In a world where diets are shifting like never before, food companies are adjusting their game plans or risk getting left in the dust. With one in five U.S. households reportedly housing a GLP-1 user by May 2026, the food game looks more like a strategic chess match than ever. Balancing taste, nutrition, and price is no...

Continue Reading
Mondel?z Bites into Undercover: Snack Market Impact

Updated Category News Views 0

Snack World Shake-Up: Mondel?z Steps In Ever find yourself browsing the snack aisle, wondering how many brands are duking it out for shelf space? Well, brace yourself, because Mondel?z International — the big cheese in the global snack game — is grabbing a sizeable bite of Undercover Snacks. This is no small news in the land of chocolate-covered and frosted quinoa...

Continue Reading
Cboe's Third Quarter Packs a Punch with Strong Gains

Updated Category News Views 27

Making Waves in the Market There's no sugar-coating it—Cboe Global Markets has had a hell of a third quarter in 2026. With their diluted EPS climbing to a record $4.08, a 43% jump from last year, it's no surprise their stock ticker, CBOE, is catching some eyes. Adjusted diluted EPS also made a splash, soaring 36% to $3.63 compared to 2025 figures. Their strategic moves...

Continue Reading
ACACIA's Big Move with Bel-Mac and Seashore: Will It Pay Off?

Updated Category News Views 125

A New Powerhouse in Roofing Services? Take a seat, folks—we're talking about a regional shakeup in the world of roofing and exterior building. ACACIA Exterior Building Group, based out of Alexandria, Virginia, just tightened its grip on the Mid-Atlantic and Gulf Coast markets by investing in Bel-Mac Roofing and Seashore Construction. This ain't just your run-of-the-mill...

Continue Reading
Scientology Ministers Train First Responders in Philippines

Updated Category News Views 68

Boots on the Ground: Scientology's Goodwill Tour In a world where chaos often reigns supreme, it's refreshing to see someone step up to support those who stare down danger daily. The Scientology Volunteer Ministers have taken it upon themselves to empower those on the front lines in the Philippines. From bustling Manila to the calmer waves of Davao City, these ministers...

Continue Reading
Alfa Laval Secures EUR 1B Credit Facility Extension

Updated Category News Views 56

Alfa Laval Banks on a New Financial Horizon Forget your morning rituals, Alfa Laval just pulled off a maneuver that's got industry tongues wagging. Thanks to a new EUR 1 billion revolving credit facility, they've bolstered their financial defenses, setting a robust foundation for the future. The facility, no dink-and-dunk affair, carries an initial five-year maturity. And...

Continue Reading
Embraer ADS Ratio Change: Impact on Investors

Updated Category News Views 14

ADS Ratio Adjustments: What's the Big Deal? Well, here we go. Embraer, that Brazilian aerospace heavyweight, has just kicked up some dust with its latest move concerning American Depositary Shares (ADS). Now, don't expect any shock and awe value-explosion gimmicks, but there's a shift in the air. Understanding the Split Let's cut to the financial meat: Embraer’s mucking...

Continue Reading
Modular Building Boom Shakes Up Asian Construction

Updated Category News Views 112

Building the Future, One Module at a Time What's ticking in the world of construction? Modular buildings, my friends. They're generating buzz at the Fourth Linyi Mall International Buyers Conference held last week, and for good reasons. If you're not following, China is rolling out prefabricated houses like they're the next big thing since sliced bread, leaving buyers in...

Continue Reading
Barco Brings HDR Cinema Home with Kinepolis Kortrijk

Updated Category News Views 302

A New Chapter in Cinema Projection Ah, Belgium, the land of waffles and apparently, cutting-edge cinema tech. That's right, Barco is bringing their HDR by Barco system to its own backyard in Kortrijk, teaming up with Kinepolis to shake things up. It's not just any expansion—it's a homecoming of sorts. The company's laser cinema magic has already made face time in the...

Continue Reading

Top 5 Most Recently Viewed Articles

Arctiq Welcomes New CFO Tom Hitselberger to Accelerate Growth

Updated Category News Views 158

Arctiq Welcomes New CFO Tom Hitselberger Arctiq, a prominent player in the IT solutions and managed services sector, has announced that Tom Hitselberger is stepping into the role of Chief Financial Officer. This exciting move is set to significantly impact the company as it further solidifies its position in the market. Tom Hitselberger's Role and Vision In his new...

Continue Reading
Investors Alert: Upcoming Deadline in DexCom Class Action Lawsuit

Updated Category News Views 114

Critical Deadline Approaches for DexCom Investors As many investors in DexCom, Inc. prepare for an important date, Glancy Prongay & Murray LLP aims to remind them about their rights in the ongoing class action lawsuit. With an impending deadline for filing a lead plaintiff motion approaching, those who have purchased securities during a specific period should stay...

Continue Reading
Celebrating Dr. Reed V. Tuckson: A Leader in Health Education

Updated Category News Views 324

Dr. Reed V. Tuckson Receives the Prominent Health Award Renowned health advocate, Dr. Reed V. Tuckson, has recently been honored with the prestigious Elizabeth Fries Health Education Award. This accolade celebrates his ongoing commitment to enhancing health outcomes for all and empowering individuals to make informed health decisions. Dr. Tuckson’s initiatives are a...

Continue Reading
Canadian Stock Market Soars: Key Gains Across Sectors

Updated Category News Views 405

Canadian Stock Market Overview The Canadian stock market experienced a notable upswing, showcasing positive momentum driven by several key sectors. The Toronto Stock Exchange witnessed significant gains, primarily fueled by advancements in healthcare, energy, and utilities sectors. By the close, the S&P/TSX Composite recorded an increase of 0.61%, with various stocks...

Continue Reading
Illumina Launches New Sequencing Systems to Boost Growth

Updated Category News Views 113

Illumina Introduces Innovative Sequencing Systems Illumina (NASDAQ: ILMN) has made headlines with the launch of its new benchtop sequencing systems, the MiSeq i100 and MiSeq i100 Plus. This move is particularly significant given Baird's recent affirmation of a Neutral rating with a price target set at $124.00. These new systems are designed to meet the growing demands of...

Continue Reading